Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Ruda Slaska – page 2

23 clinical trials in Ruda Slaska, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Ruda Slaska at a glance
23
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

23 trials in Ruda Slaska

Open in trial search

Dyslipidaemia

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Atrial fibrillation

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Embonate
  • Sponsor:Novo Nordisk A/S

Obesity+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ly3437943 Sodium
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Diabetic neuropathy

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ly3556050
  • Sponsor:Eli Lilly & Co.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Ruda Slaska

What the registry says about research in the country

01 Cardiovascular Disease Management

Innovative research exploring treatments for atherosclerotic cardiovascular disease, focusing on novel therapies to reduce major cardiovascular events and improve patient outcomes.

  • Atherosclerotic Heart Disease
  • Cardiovascular Event Prevention
  • Lipid Management Therapies

Studies are evaluating new compounds like obicetrapib and inclisiran for reducing cardiovascular risks.

02 Metabolic Disorders

Advanced clinical research targeting Type 2 Diabetes and obesity management, with studies comparing effectiveness of innovative treatments for weight management and glycemic control.

  • Diabetes Management
  • Weight Control
  • Metabolic Health

Groundbreaking trials examining new therapeutic options including tirzepatide and retatrutide.

03 Cardiac Rhythm Management

Comprehensive studies addressing atrial fibrillation and heart failure, investigating novel therapeutic approaches for improved cardiac function and patient safety.

  • Heart Rhythm Disorders
  • Heart Failure Treatment
  • Anticoagulation Therapy

Research includes comparative studies of anticoagulants and innovative heart failure combination therapies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.